Treatment options for cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma: a systematic review
I Michelon, GC Nachtigal, MI Dacoregio… - Journal of Cancer …, 2024 - Springer
Purpose There is no agreed-upon standard option for patients with locally advanced head
and neck squamous cell carcinoma (LA HNSCC) unfit for cisplatin-based regimens …
and neck squamous cell carcinoma (LA HNSCC) unfit for cisplatin-based regimens …
Current and future perspectives in unresectable locally advanced esophageal squamous cell cancer
W Zhang, M Zhu, Y Xiang, Y Sun, S Li… - Oncology …, 2024 - spandidos-publications.com
Definitive concurrent chemoradiotherapy has been the main standard treatment method for
unresectable locally advanced esophageal squamous cell cancer (ESCC) since 1999 …
unresectable locally advanced esophageal squamous cell cancer (ESCC) since 1999 …
Fibroblast stromal support model for predicting human papillomavirus-associated cancer drug responses
CD James, RL Lewis, AL Fakunmoju, AJ Witt… - Journal of …, 2024 - journals.asm.org
Currently, there are no specific antiviral therapeutic approaches targeting Human
papillomaviruses (HPVs), which cause around 5% of all human cancers. Specific antiviral …
papillomaviruses (HPVs), which cause around 5% of all human cancers. Specific antiviral …
Metastatic patterns and treatment options for head and neck cutaneous squamous cell carcinoma
D Iancu, A Fulga, D Vesa… - Molecular and …, 2024 - spandidos-publications.com
According to current predictions, one‑fifth of all Americans will develop skin cancer during
their lifetime. Cutaneous squamous cell carcinoma (cSCC) most commonly occurs in the …
their lifetime. Cutaneous squamous cell carcinoma (cSCC) most commonly occurs in the …
[HTML][HTML] The Addition of Docetaxel to Platinum Based Concurrent Chemoradiation Improves the Response and Survival in Patients with Locally Advanced Squamous …
A Rayan, S Shehata, MM Aboshanif… - Eurasian Journal of …, 2024 - accscience.com
Objectives: We aimed from the current study to explore the added benefits of docetaxel to
platinum based CCRT in locally advanced HNSCC regarding response rates, locoregional …
platinum based CCRT in locally advanced HNSCC regarding response rates, locoregional …
Ways to improve the results of conservative therapy of malignant tumors of the head and neck organs. Part I. The current state of the issue
OK Kurpeshev - Russian Journal of Oncology, 2024 - rjonco.com
The review analyzes the results of conservative therapy of patients with the head and neck
cancer. Despite the use of modern radiation and drug technologies, the results of treatment …
cancer. Despite the use of modern radiation and drug technologies, the results of treatment …
[HTML][HTML] Radioterapia a intensità modulata con boost simultaneo più cetuximab in pazienti con carcinoma a cellule squamose in stadio localmente avanzato del …
F Chillari, S Parisi, G Ferrantelli… - Recenti Progressi in …, 2024 - recentiprogressi.it
Introduzione e obiettivo. Il carcinoma a cellule squamose in stadio localmente avanzato del
distretto testa-collo (LA-Hnscc) è una sfida terapeutica e la comunità scientifica ricerca …
distretto testa-collo (LA-Hnscc) è una sfida terapeutica e la comunità scientifica ricerca …